CMSC: Consortium of Multiple Sclerosis Centers
Conference Coverage
What’s the evidence for stopping DMTs in MS patients?
NEW ORLEANS – In some situations it might be reasonable to discuss cessation of DMTs with patients.
Conference Coverage
DMD use during pregnancy low, study finds
NEW ORLEANS – The proportion of women with MS and a live birth receiving DMD treatment was low, but a relapse before pregnancy was more likely to...
Conference Coverage
Revisions coming to McDonald Criteria for MS
NEW ORLEANS – Increased emphasis on cerebrospinal fluid evaluation for some cases is one of the changes being considered.
Conference Coverage
Disease-Modifying Drug Treatment Before, During, and After Pregnancy in Women With MS
NEW ORLEANS—In a population of women with multiple sclerosis (MS) and a live birth, the rate of disease-modifying drug treatment...
Conference Coverage
Study offers snapshot of common MS comorbidities
NEW ORLEANS – Which comes first: Multiple sclerosis or the comorbidities?
Conference Coverage
Effective monitoring of DMTs for multiple sclerosis can be tricky
NEW ORLEANS – Documenting lab results in electronic medical records from patients coming from outside clinics proved to be difficult.
Conference Coverage
Phase II Data Show Safety and Efficacy of Ozanimod for Relapsing MS
NEW ORLEANS—Ozanimod demonstrated durable efficacy with a favorable safety profile in patients continuing ozanimod for 120 weeks...
Conference Coverage
Risk tolerance to MS therapies varies widely
NEW ORLEANS – Males had higher tolerances to all surveyed risks.
Conference Coverage
Alemtuzumab May Prevent MRI Lesions for Six Years in Patients With Highly Active Disease
NEW ORLEANS—Most patients with relapsing-remitting multiple sclerosis (MS) with highly active disease remain free of new MRI...
Conference Coverage
What Are Patients With MS Saying About Day-to-Day Life and Treatment?
NEW ORLEANS—Two studies presented at the 31st Annual Meeting of the Consortium of Multiple Sclerosis (MS) Centers examined the...
Conference Coverage
Should Patients on B Cell–Depleting Therapies Be Immunized Against Influenza?
NEW ORLEANS—Immunizing patients on B cell–depleting therapies against influenza using the inactivated virus vaccine may be...
Conference Coverage
Does a High-Quality Diet Affect Disability Status in Patients With MS?
NEW ORLEANS—A diet high in fruits, vegetables, legumes, and whole grains and low in sugar and red meat is associated with less...
Conference Coverage
Light Physical Activity May Improve Physical Function in Older Patients With MS
NEW ORLEANS—Older adults with multiple sclerosis (MS) who engaged more in light physical activity demonstrated better physical...
Conference Coverage
Number Needed to Treat Analyses Comparing Alemtuzumab With Ocrelizumab
NEW ORLEANS—Two-year analyses show that fewer patients required treatment with alemtuzumab than ocrelizumab to prevent one...
Conference Coverage
Pooled Data Show Benefits of Cladribine Tablets on Relapse Rates and Disability Progression in Patients With MS
NEW ORLEANS—Analysis of pooled data from the CLARITY and ONWARD studies showed that cladribine tablets 3.5 mg/kg decreased...